Showing results (91-100 of 133) with videos related to

Sort By:
Pageof 14
Journal of Translational Medicine|September 28, 2011
Proteomic detection of a large amount of SCGFα in the stroma of GISTs after imatinib therapyLuca Da Riva, Fabio Bozzi, Piera Mondellini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2012
KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumorsClaudia Miranda, Martina Nucifora, Francesca Molinari, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 17, 2005
Cyclooxygenase-2 expression in FAP patients carrying germ line MYH mutationsMilo Frattini, Ileana Carnevali, Stefano Signoroni, et al.
Molecular Oncology|April 10, 2013
Are two better than one? A novel double-mutant KIT in GIST that responds to ImatinibElena Conca, Claudia Miranda, Valentina Dal Col, et al.
Endocrine-Related Cancer|May 30, 2008
Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancerVera Cappelletti, Manuela Gariboldi, Loris De Cecco, et al.
Endocrine-Related Cancer|November 8, 2012
DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cellsDebora Degl'Innocenti, Paola Romeo, Eva Tarantino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2010
Functional mapping of receptor tyrosine kinases in myxoid liposarcomaTiziana Negri, Emanuela Virdis, Silvia Brich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patientsDelia Mezzanzanica, Marina Fabbi, Marina Bagnoli, et al.
Endocrine-Related Cancer|June 22, 2011
Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphismMaria Grazia Borrello, Antonella Aiello, Bernard Peissel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosisStefano Signoroni, Milo Frattini, Tiziana Negri, et al.
Pageof 14